Gautam Vivek, D'Avanzo Carla, Berezovska Oksana, Tanzi Rudolph E, Kovacs Dora M
Genetics and Aging Research Unit, MassGeneral Institute for Neurodegenerative Disease, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA, 02129, USA.
MassGeneral Institute for Neurodegenerative Disease, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA, 02129, USA.
Mol Neurodegener. 2015 Jul 23;10:31. doi: 10.1186/s13024-015-0028-5.
Accumulation of the β-amyloid peptide (Aβ) is a major pathological hallmark of Alzheimer's disease (AD). Recent studies have shown that synaptic Aβ toxicity may directly impair synaptic function. However, proteins regulating Aβ generation at the synapse have not been characterized. Here, we sought to identify synaptic proteins that interact with the extracellular domain of APP and regulate Aβ generation.
Affinity purification-coupled mass spectrometry identified members of the Synaptotagmin (Syt) family as novel interacting proteins with the APP ectodomain in mouse brains. Syt-1, -2 and -9 interacted with APP in cells and in mouse brains in vivo. Using a GST pull-down approach, we have further demonstrated that the Syt interaction site lies in the 108 amino acids linker region between the E1 and KPI domains of APP. Stable overexpression of Syt-1 or Syt-9 with APP in CHO and rat pheochromocytoma cells (PC12) significantly increased APP-CTF and sAPP levels, with a 2 to 3 fold increase in secreted Aβ levels in PC12 cells. Moreover, using a stable knockdown approach to reduce the expression of endogenous Syt-1 in PC12 cells, we have observed a ~ 50% reduction in secreted Aβ generation. APP processing also decreased in these cells, shown by lower CTF levels. Lentiviral-mediated knock down of endogenous Syt-1 in mouse primary neurons also led to a significant reduction in both Aβ40 and Aβ42 generation. As secreted sAPPβ levels were significantly reduced in PC12 cells lacking Syt-1 expression, our results suggest that Syt-1 regulates Aβ generation by modulating BACE1-mediated cleavage of APP.
Altogether, our data identify the synaptic vesicle proteins Syt-1 and 9 as novel APP-interacting proteins that promote Aβ generation and thus may play an important role in the pathogenesis of AD.
β-淀粉样肽(Aβ)的积累是阿尔茨海默病(AD)的主要病理标志。最近的研究表明,突触Aβ毒性可能直接损害突触功能。然而,调节突触处Aβ生成的蛋白质尚未得到鉴定。在此,我们试图鉴定与APP细胞外结构域相互作用并调节Aβ生成的突触蛋白。
亲和纯化结合质谱分析确定了突触结合蛋白(Syt)家族成员是小鼠脑中与APP胞外结构域新的相互作用蛋白。Syt-1、-2和-9在细胞和小鼠脑内均与APP相互作用。采用谷胱甘肽S-转移酶(GST)沉降法,我们进一步证明Syt的相互作用位点位于APP的E1和KPI结构域之间的108个氨基酸的连接区域。在CHO细胞和大鼠嗜铬细胞瘤细胞(PC12)中,Syt-1或Syt-9与APP稳定共表达显著增加了APP-CTF和sAPP水平,PC12细胞中分泌的Aβ水平增加了2至3倍。此外,采用稳定敲低方法降低PC12细胞内源性Syt-1的表达,我们观察到分泌的Aβ生成减少了约50%。这些细胞中的APP加工也减少,表现为CTF水平降低。慢病毒介导的小鼠原代神经元内源性Syt-1敲低也导致Aβ40和Aβ42生成显著减少。由于缺乏Syt-1表达的PC12细胞中分泌的sAPPβ水平显著降低,我们的结果表明Syt-1通过调节β-分泌酶1(BACE1)介导的APP切割来调节Aβ生成。
总之,我们的数据确定突触小泡蛋白Syt-1和9是促进Aβ生成的新的APP相互作用蛋白,因此可能在AD的发病机制中起重要作用。